Cargando…

Malignant behaviorial characteristics of CD133(+/−) glioblastoma cells from a Northern Chinese population

Following emergence of the tumor stem cell theory, the increasing number of related studies demonstrates the theory’s growing importance in cancer research and its potential for clinical applications. Few studies have addressed the in vitro or in vivo properties of glioma stem cells from a Han Chine...

Descripción completa

Detalles Bibliográficos
Autores principales:	LIU, XIAOZHI, CHEN, LEI, JIANG, ZHONGMIN, WANG, JUNFEI, SU, ZHIGUO, LI, GANG, YU, SHIZHU, LIU, ZHENLIN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524257/ https://www.ncbi.nlm.nih.gov/pubmed/23251243 http://dx.doi.org/10.3892/etm.2012.747

Ejemplares similares

Cognitive and behaviorial features of a cohort of patients in COVID-19 post-acute phase
por: Canu, Elisa, et al.
Publicado: (2021)

A comprehensive investigation of the reaction behaviorial features of coke with different CRIs in the simulated cohesive zone of a blast furnace
por: Lv, Qing Q., et al.
Publicado: (2021)

CD133 Expression in Glioblastoma Multiforme: A Literature Review
por: Ahmed, Syed Ijlal, et al.
Publicado: (2018)

Analysis of gene expression and chemoresistance of CD133(+ )cancer stem cells in glioblastoma
por: Liu, Gentao, et al.
Publicado: (2006)

Cancer stem cells CD133 and CD24 in colorectal cancers in Northern Iran
por: Nosrati, Anahita, et al.
Publicado: (2016)

Coexpression analysis of CD133 and CD44 identifies Proneural and Mesenchymal subtypes of glioblastoma multiforme
por: Brown, Daniel V., et al.
Publicado: (2015)

Mesenchymal stem cell-like properties of CD133(+) glioblastoma initiating cells
por: Pavon, Lorena Favaro, et al.
Publicado: (2016)

Preferential Association of Lissencephaly-1 Gene Expression with CD133+ Glioblastoma Cells
por: Brehar, Felix Mircea, et al.
Publicado: (2017)

CD133 Regulates IL-1β Signaling and Neutrophil Recruitment in Glioblastoma
por: Lee, Seon Yong, et al.
Publicado: (2017)

An Overview of CD133 as a Functional Unit of Prognosis and Treatment Resistance in Glioblastoma
por: Joyce, Thomas, et al.
Publicado: (2023)

Biological characteristics of CD133(+) cells in nasopharyngeal carcinoma
por: ZHUANG, HUI-WEN, et al.
Publicado: (2013)

Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme
por: Kase, Marju, et al.
Publicado: (2013)

Selective Lentiviral Gene Delivery to CD133-Expressing Human Glioblastoma Stem Cells
por: Bayin, N. Sumru, et al.
Publicado: (2014)

A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells
por: Ahmed, Eroje M., et al.
Publicado: (2018)

Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors
por: Liu, Qinghai, et al.
Publicado: (2009)

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
por: Yu, Ji-wei, et al.
Publicado: (2010)

Study on the Biological Characteristics of CD133(+) Cells Interfered by RNA Interference in Gastric Cancer
por: Yu, Ji-wei, et al.
Publicado: (2014)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

Chromenopyrimidinone Controls Stemness and Malignancy by suppressing CD133 Expression in Hepatocellular Carcinoma
por: Song, Yeonhwa, et al.
Publicado: (2020)

Human CD133-positive hematopoietic progenitor cells enhance the malignancy of breast cancer cells
por: Zhang, Zhe, et al.
Publicado: (2020)

Pathological features of transplanted tumor established by CD133 positive TJ905 glioblastoma stem-like cells
por: Jin, Feng, et al.
Publicado: (2015)

AEG-1 expression correlates with CD133 and PPP6c levels in human glioma tissues
por: Guo, Jia, et al.
Publicado: (2014)

CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial
por: Wang, Yao, et al.
Publicado: (2018)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

All-trans retinoic acid suppresses malignant characteristics of CD133-positive thyroid cancer stem cells and induces apoptosis
por: Mei, Dan, et al.
Publicado: (2017)

Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression
por: Perazzoli, Gloria, et al.
Publicado: (2015)

Impact of Blood Vessel Quantity and Vascular Expression of CD133 and ICAM-1 on Survival of Glioblastoma Patients
por: Minajeva, Ave, et al.
Publicado: (2017)

Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity
por: Brown, Daniel V., et al.
Publicado: (2017)

Production and Evaluation of an Avian IgY Immunotoxin against CD133+ for Treatment of Carcinogenic Stem Cells in Malignant Glioma: IgY Immunotoxin for the Treatment of Glioblastoma
por: Chavez-Cortez, Elda-Georgina, et al.
Publicado: (2019)

Isolation and characteristics of CD133(−)/A2B5(+) and CD133(−)/A2B5(−) cells from the SHG139s cell line
por: HAN, YONG, et al.
Publicado: (2015)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma
por: Liu, Chao Lien, et al.
Publicado: (2020)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness
por: Brugnoli, Federica, et al.
Publicado: (2013)

Paclitaxel inhibits the migration of CD133+ U251 malignant glioma cells by reducing the expression of glycolytic enzymes
por: Long, Niya, et al.
Publicado: (2020)

Investigating the Link between Molecular Subtypes of Glioblastoma, Epithelial-Mesenchymal Transition, and CD133 Cell Surface Protein
por: Zarkoob, Hadi, et al.
Publicado: (2013)

Imaging and Selective Elimination of Glioblastoma Stem Cells with Theranostic Near-Infrared-Labeled CD133-Specific Antibodies
por: Jing, Hua, et al.
Publicado: (2016)

Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57
por: Zhu, Xuekai, et al.
Publicado: (2014)

CD133 Role in Oral Carcinogenesis
por: Luna, Ealber Carvalho Macedo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r2oe51nbl2jcq36di68i8upeij